Skip to main content

Exfoliation Syndrome and Glaucoma

  • Chapter
  • First Online:
The Glaucoma Book

Abstract

Exfoliative glaucoma (XFG) is the most common type of secondary open-angle glaucoma.1 Its worldwide prevalence makes it critical for ophthalmologists to be familiar with the full clinical spectrum of the disease.1–3 Exfoliation syndrome (XFS) and XFG were initially described in 1917 by the Finnish ophthalmologist John Lindberg. In 1924, it was determined that XFG develops from XFS. Both conditions currently affect 60-70 million people worldwide. Of these, 15-17 million people have increased intraocular pressure (IOP) and 5-6 million are estimated to suffer from XFG.3 Both XFS and XFG are characterized by the systemic synthesis and accumulation of an abnormal fibrillar material, called exfoliation material. Originally it was believed that the sole source of this abnormal material is the lens. The terms exfoliation material, XFS, XFG, and capsular glaucoma were introduced based on this early theory. True exfoliation of the lens capsule is a different and an exceedingly rare entity, which occurs as a consequence of thermal damage of the lens.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45:265–315.

    Article  CAS  PubMed  Google Scholar 

  2. Ringvold A. Epidemiology of the pseudoexfoliation syndrome. A review. Acta Ophthalmol Scand. 1999;77:371–375.

    Article  CAS  PubMed  Google Scholar 

  3. Ritch R, Schlotzer-Schrehardt U, Konstas AG. Why is glaucoma associated with exfoliation syndrome? Prog Retin Eye Res. 2003;22:253–275.

    Article  PubMed  Google Scholar 

  4. Thorleifsson G, Magnusson KP, Sulem P, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science. 2007;317:1397–1400.

    Article  CAS  PubMed  Google Scholar 

  5. Fingert JH, Alward WA, Kwon YH, Wang K, Streb LM. LOXL1 mutations are associated with exfoliation syndrome in patients from the Midwestern United States. Am J Ophthalmol. 2007;144:974–975.

    Article  PubMed  Google Scholar 

  6. Pasutto F, Krumbiegel M, Marin CY, et al. Associations of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci. 2008;49:1459–1463.

    Article  PubMed  Google Scholar 

  7. Ozaki M, Lee KYC, Vithana FN, et al. Association of LOXL1 gene polymorphism with pseudoexfoliation in the Japanese. Invest Ophthalmol Vis Sci. 2008;49:3976–3980.

    Article  PubMed  Google Scholar 

  8. Hayashi H, Gotoh N, Ueda Y, Nakanishi H, Yoshimura N. Lysyl oxidase-like 1 polymorphism and exfoliation syndrome in the Japanese population. Am J Ophthalmol. 2008;145:582–585.

    Article  CAS  PubMed  Google Scholar 

  9. Schlötzer-Schrehardt U, Naumann GOH. Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma. Invest Ophthalmol Vis Sci. 1995;36:1750–1764.

    PubMed  Google Scholar 

  10. Naumann GOH, Shclötzer-Schrehardt U, Kühle M. Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Ophthalmology. 1998;105:951–968.

    Article  CAS  PubMed  Google Scholar 

  11. Koliakos GG, Konstas AGP, Schrehardt-Schloetzer U, Bufidis T, Georgiadis N, Ringvold A. Ascorbic acid concentration is reduced in the aqueous humor of patients with exfoliation syndrome. Am J Ophthalmol. 2002;134:879–883.

    Article  CAS  PubMed  Google Scholar 

  12. Visontai ZS, Horváth T, Kollai M, Holló G. Decreased cardiovagal regulation in exfoliation syndrome. J Glaucoma. 2008;17:133–138.

    Article  PubMed  Google Scholar 

  13. Visontai Z, Merisch B, Kollai M, Holló G. Increase of carotid artery stiffness and decrease of baroreflex sensitivity in exfoliation syndrome and glaucoma. Br J Ophthalmol. 2006;90:563–567.

    Article  CAS  PubMed  Google Scholar 

  14. Mitchell P, Wang JJ, Smith W. Association of pseudoexfolation syndrome with increased vascular risk. Am J Ophthalmol. 1997;124: 85–687.

    CAS  PubMed  Google Scholar 

  15. Tarkkanen A, Kivelä T. Cumulative incidence of converting from clinically unilateral to bilateral exfoliation syndrome. J Glaucoma. 2004;13:181–184.

    Article  PubMed  Google Scholar 

  16. Puska P. Unilateral exfoliation syndrome: conversion to bilateral exfoliation and to glaucoma. A prospective 10-year follow-up study. J Glaucoma. 2002;11:517–524.

    Article  PubMed  Google Scholar 

  17. Konstas AGP, Matziris DA, Stewart WC. Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol. 1997;28:111–117.

    CAS  Google Scholar 

  18. Konstas AGP, Holló G, Astakhov YS, et al. Presentation and long-term follow-up of exfoliation glaucoma in Greece, Spain, Russia and Hungary. Eur J Ophthalmol. 2006;16:60–66.

    CAS  PubMed  Google Scholar 

  19. Thygesen J. Ocular clinical findings in exfoliation syndrome. In: Holló G, Konstas AGP, eds. Exfoliation Syndrome and Exfoliative Glaucoma. Savona, Italy: Dogma S.r.l; 2008:105–112.

    Google Scholar 

  20. Teus MA, de Benito-Llopis L. Update on cataract surgery in exfoliation syndrome. In: Holló G, Konstas AGP, eds. Exfoliation Syndrome and Exfoliative Glaucoma. Savona, Italy: Dogma S.r.l; 2007:127–132.

    Google Scholar 

  21. Vesti E, Kivel AT. Exfoliation syndrome and exfoliation glaucoma. Prog Retin Eye Res. 2000;19:268–345.

    Article  Google Scholar 

  22. Konstas AGP, Tsironi S, Kozobolis VP. Medical therapy of exfoliative glaucoma. In: Holló G, Konstas AGP, eds. Exfoliation Syndrome and Exfoliative Glaucoma. Savona, Italy: Dogma S.r.l; 2008:137–144.

    Google Scholar 

  23. Konstas AGP, Holló G, Akopov EL, et al. Factors associated with long-term progression or stability in exfoliation glaucoma. Arch Ophthalmol. 2004;122:29–33.

    Article  PubMed  Google Scholar 

  24. Konstas AGP, Tsironi S, Ritch R. Current concepts in the pathogenesis and management of exfoliation syndrome and exfoliative glaucoma. Compr Ophthalmol Update. 2006;7:131–141.

    PubMed  Google Scholar 

  25. Takki KK, Klemetti A, Valle O. The IOP-lowering effect of timolol in simple and capsular glaucoma. A multicenter study in Finland. Graefes Arch Clin Exp Ophthalmol. 1982;218:83–87.

    Article  CAS  PubMed  Google Scholar 

  26. Blika S, Saunte E. Timolol maleate in the treatment of glaucoma simplex and glaucoma capsulare. A three-year follow up study. Acta Ophthalmol (Copenh). 1982;60:967–976.

    Article  CAS  Google Scholar 

  27. Konstas AG, Matziris DA, Gate EA, Stewart WC. Effect of timolol on the diurnal intraocular pressure in exfoliation and primary open-angle glaucoma. Arch Ophthalmol. 1997;115:975–979.

    CAS  PubMed  Google Scholar 

  28. Heijl A, Strahlman E, Sverrisson T, et al. A comparison of dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hypertension. Ophthalmology. 1997;104:137–142.

    CAS  PubMed  Google Scholar 

  29. Konstas AGP, Maltezos A, Bufidis T, Hudgins AG, Stewart WC. Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma. Eye. 2000;14:73–77.

    PubMed  Google Scholar 

  30. Parmaksiz S, Yuksel N, Karabas VL, Ozkan B, Demirci G, Caglar Y. A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma. Eur J Ophthalmol. 2006;16:73–80.

    CAS  PubMed  Google Scholar 

  31. Konstas AG, Kozobolis VP, Tersis I, Leech J, Stewart WC. The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma. Eye. 2003;17:41–46.

    Article  CAS  PubMed  Google Scholar 

  32. Konstas AG, Mylopoulos N, Karabatsas CH, et al. Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma. Eye. 2004;18:893–899.

    Article  CAS  PubMed  Google Scholar 

  33. Konstas AGP, Kozobolis VP, Katsimpris IE, et al. Efficacy and safety of latanoprost versus travoprost in exfoliative glaucoma patients. Ophthalmology. 2007;114:653–657.

    Article  PubMed  Google Scholar 

  34. Konstas AGP, Holló G, Irkec M, et al. Diurnal IOP control with bimatoprost vs latanoprost in exfoliative glaucoma: a crossover observer-masked 3-center study. Br J Ophthalmol. 2007;91:757–760.

    Article  CAS  PubMed  Google Scholar 

  35. Stewart WC, Konstas AGP, Nelson LA, Kruft B. Meta-analysis of 24-hour intraocular pressure studies evaluating efficacy of glaucoma medicines. Ophthalmology. 2008;115:1117–1122.

    Article  PubMed  Google Scholar 

  36. Petounis A, Mylopoulos N, Kandarakis A, Andreanos D, Dimitrakoulias N. Comparison of additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized open-label, multicenter study in Greece. J Glaucoma. 2001;10:316–324.

    Article  CAS  PubMed  Google Scholar 

  37. Odberg T. Laser therapy of exfoliative glaucoma. In: Holló G, Konstas AGP, eds. Exfoliation Syndrome and Exfoliative Glaucoma. Savona, Italy: Dogma S.r.l; 2008:149–153.

    Google Scholar 

  38. Odberg T, Sandvik L. The medium and long-term efficacy of primary argon laser trabeculoplasty in avoiding topical medication in open angle glaucoma. Acta Ophthalmol Scand. 1999;77:176–181.

    Article  CAS  PubMed  Google Scholar 

  39. Threlkeld A, Hertzmark E, Sturm RT, et al. Comparative study of the efficacy of argon laser trabeculoplasty for exfoliation and primary open-angle glaucoma. J Glaucoma. 1996;5:311–316.

    Article  CAS  PubMed  Google Scholar 

  40. Higginbotham EJ, Richardson TM. Response of exfoliation glaucoma to laser trabeculoplasty. Br J Ophthalmol. 1986;70:837–839.

    Article  CAS  PubMed  Google Scholar 

  41. Psilas P, Prevezas D, Petroutsos G, et al. Comparative study of argon laser trabeculoplasty in primary open-angle and pseudoexfoliation glaucoma. Ophthalmologica. 1989;198:57–63.

    Article  CAS  PubMed  Google Scholar 

  42. Tuulonen A, Niva A-K, Alanko HI. A controlled five-year follow-up study of laser trabeculoplasty as primary therapy for open-angle glaucoma. Am J Ophthalmol. 1987;104:334–338.

    CAS  PubMed  Google Scholar 

  43. Hodge WG, Damji KF, Rock W, Buhrmann R, Bowel AM, Pan Y. Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial. Br J Ophthalmol. 2005;89:1157–1160.

    Article  CAS  PubMed  Google Scholar 

  44. Melamed S, Ben Simon GJ, Levkovitch-Verbin H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma. Arch Ophthalmol. 2003;121:957–960.

    Article  PubMed  Google Scholar 

  45. Kozobolis VP, Konstas AGP. Filtering surgery in exfoliative glaucoma. In: Holló G, Konstas AGP, eds. Exfoliation Syndrome and Exfoliative Glaucoma. Savona, Italy: Dogma S.r.l; 2008:157–161.

    Google Scholar 

  46. Tφrnqvist G, Drolsum L. Trabeculectomies. A long-term study. Acta Ophthalmol (Copenh). 1991;69:450–454.

    Article  Google Scholar 

  47. Popovic V, Sjostrand J. Course of exfoliation and simplex glaucoma after primary trabeculectomy. Br J Ophthalmol. 1999;83: 305–310.

    Article  CAS  PubMed  Google Scholar 

  48. Konstas AGP, Jay JL, Marshall GE, Lee WR. Prevalence, diagnostic features and the response to trabeculectomy in exfoliation glaucoma. Ophthalmology. 1993;100:619–627.

    CAS  PubMed  Google Scholar 

  49. Drolsum L. Deep sclerectomy in patients with capsular glaucoma. Acta Ophthalmol Scand. 2003;81:567–572.

    Article  PubMed  Google Scholar 

  50. Kozobolis VP, Christodoulakis EV, Tzanakis N, Zacharopoulos I, Pallikaris IG. Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma. J Glaucoma. 2002;11:287–293.

    Article  PubMed  Google Scholar 

  51. Shaarawy T, Nguyen C, Schnyder C, Mermoud A. Five year results of viscocanalostomy. Br J Ophthalmol. 2003;87:441–445.

    Article  CAS  PubMed  Google Scholar 

  52. Wishart PK, Wishart MS, Porooshani H. Viscocanalostomy and deep sclerectomy for the surgical treatment of glaucoma: a longterm follow-up. Acta Ophthalmol Scand. 2003;81:343–348.

    Article  PubMed  Google Scholar 

  53. Jacobi PC, Dietlein TS, Krieglstein GK. Comparative study of trabecular aspiration vs trabeculectomy in glaucoma triple procedure to treat pseudoexfoliation glaucoma. Arch Ophthalmol. 1999;117: 1311–1318.

    CAS  PubMed  Google Scholar 

  54. Ritch R, Konstas AGP, Schlötzer-Schrehardt U: Exfoliation syndrome and exfoliative glaucoma. In Glaucoma: Medical diagnosis and therapy, Shaarawy TM, Sherwood MB, Hitchings RA, Crowston JG, eds, Saunders 2009;1:339–348.

    Google Scholar 

Download references

Acknowledgments

Supported in part by a Pythagoras grant (Dr. Konstas); a Hungarian National Health Grant (ETT 001/2009), (Dr. Holló); and a Horizon Award, Allergan, Inc., and Edith C. Blum Foundation, New York, NY (Dr. Ritch).

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Konstas, A.G.P., Holló, G., Ritch, R. (2010). Exfoliation Syndrome and Glaucoma. In: Schacknow, P., Samples, J. (eds) The Glaucoma Book. Springer, New York, NY. https://doi.org/10.1007/978-0-387-76700-0_39

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-76700-0_39

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-76699-7

  • Online ISBN: 978-0-387-76700-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics